June 27, 2025 - 13:18
TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 – Biocon Biologics Ltd. has announced that it has received approval from Health Canada for its innovative product, Yesafili™ (aflibercept). This significant milestone marks a pivotal moment for the company as it prepares for the first global launch of the drug, slated for July 2025.
Yesafili™ is designed to treat various eye diseases, offering a new therapeutic option for patients in need. The approval from Health Canada underscores the rigorous evaluation process that the product has undergone, ensuring its safety and efficacy for the Canadian market.
The upcoming launch is expected to enhance Biocon Biologics' footprint in the global pharmaceutical landscape, particularly in the field of ophthalmology. With this approval, the company aims to address the unmet medical needs of patients suffering from vision-threatening conditions, reinforcing its commitment to advancing healthcare solutions worldwide.
September 26, 2025 - 03:58
Democrats Push for Health Care Funding Amid Imminent Government ShutdownDemocratic leaders are making a strong case for the extension of enhanced tax credits under the Affordable Care Act (ACA) as the deadline for government funding approaches. With a potential...
September 25, 2025 - 00:45
New Study Reveals Older Adults Can Achieve Thriving HealthA recent study from Canada provides an encouraging message for older adults and their caregivers: recovery and improved health are always possible, regardless of age. Researchers at the University...
September 24, 2025 - 05:20
Harvard Public Health Dean Received $150,000 for Testimony on Tylenol and AutismIn a controversial development, the Dean of Harvard`s Public Health School has reportedly been compensated $150,000 to provide expert testimony suggesting a link between the use of Tylenol and the...
September 23, 2025 - 23:54
Santa Clara County Health Care Leaders Warn of Dire Future Amid Federal CutsSanta Clara County health care leaders expressed deep concern about the future of public health during a recent forum. With billions in anticipated revenue cuts from federal sources, they described...